CME Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.7B
-9.2%
1.9B
+14.0%
1.6B
+7.2%
1.5B
-9.1%
1.7B
Cost of Revenue
0
0
0
0
0
Gross Profit
1.7B
-9.2%
1.9B
+14.0%
1.6B
+7.2%
1.5B
-9.1%
1.7B
Operating Expenses
599.1M
+5.0%
570.4M
-9.3%
629.1M
+11.3%
565.0M
+0.4%
562.7M
R&D
83.3M
0
0
0
-100.0%
70.9M
SG&A
262.6M
-19.9%
327.8M
-10.0%
364.2M
+5.4%
345.7M
+33.5%
259.0M
Operating Income
1.1B
-15.5%
1.3B
+28.5%
1.0B
+4.8%
972.6M
-13.9%
1.1B
EBITDA
1.2B
-14.5%
1.4B
+26.4%
1.1B
+4.4%
1.1B
-13.0%
1.2B
Net Income
1.0B
-9.7%
1.2B
-2.4%
1.2B
+30.3%
908.0M
-11.4%
1.0B
EPS (Basic)
$2.89
-11.1%
$3.25
+0.0%
$3.25
+30.5%
$2.49
-11.4%
$2.81
EPS (Diluted)
$2.88
-9.4%
$3.18
-1.9%
$3.24
+30.1%
$2.49
-11.4%
$2.81
Shares (Diluted)
361.3M
-0.5%
363.2M
+0.8%
360.2M
-0.1%
360.4M
+0.0%
360.4M
CME (CME) โ€” Financials